Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

JOURNAL ARTICLE published September 2016 in Annals of Oncology

Authors: D.P. Modest | I. Ricard | V. Heinemann | S. Hegewisch-Becker | W. Schmiegel | R. Porschen | S. Stintzing | U. Graeven | D. Arnold | L.F. von Weikersthal | C. Giessen-Jung | A. Stahler | H.J. Schmoll | A. Jung | T. Kirchner | A. Tannapfel | A. Reinacher-Schick